Trojan horse” approach may enable ‘antigen-independent’ therapy with potential to treat cancers not traditionally amenable to immunotherapy.
Scientists at the Icahn School of Medicine at Mount Sinai have developed an experimental immunotherapy that takes an unconventional approach to metastatic cancer: instead of going after cancer cells ...
A new study led by researchers at the Johns Hopkins Kimmel Cancer Center, its Bloomberg~Kimmel Institute for Cancer ...
News-Medical.Net on MSN
Trojan horse immunotherapy opens tumors to immune system attack
Scientists at the Icahn School of Medicine at Mount Sinai have developed an experimental immunotherapy that takes an unconventional approach to metastatic cancer: instead of going after cancer cells ...
A new cancer therapy wakes up immune cells inside tumors and turns them against cancer.
Researchers have identified a promising new weapon against triple-negative breast cancer, one of the most aggressive forms of ...
Researchers have uncovered a stealthy way pancreatic cancer disarms the immune system, using tiny molecular messengers to ...
Scientists at the Icahn School of Medicine at Mount Sinai have developed an experimental immunotherapy that takes an unconventional approach to metastatic cancer: instead of going after cancer cells ...
KAIST researchers unveil a new cancer therapy that reprograms immune cells inside tumours, eliminating lab-based CAR ...
Study conducted in a collaboration between MEDSIR and University Hospital Vall d'Hebron to evaluate bexmarilimab plus standard-of-care doxorubicin in a high-unmet-need frontline setting. TURKU, FI / ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results